NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Total Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Total Current Assets | ₹572 Cr | ₹520 Cr | ₹468 Cr | ₹120 Cr | ₹96 Cr |
What is the latest Total Current Assets ratio of NATH BIOGENES (INDIA) ?
Year | Total Current Assets |
---|---|
Mar2024 | ₹572 Cr |
Mar2023 | ₹520 Cr |
Mar2022 | ₹468 Cr |
Mar2013 | ₹120 Cr |
Mar2012 | ₹96 Cr |
How is Total Current Assets of NATH BIOGENES (INDIA) Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹572 Cr | 9.97 | |
Mar2023 | ₹520 Cr | 11.13 | |
Mar2022 | ₹468 Cr | 290.62 | |
Mar2013 | ₹120 Cr | 24.45 | |
Mar2012 | ₹96 Cr | - |
Compare Total Current Assets of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹392.7 Cr | 1.5% | 9.3% | -0.2% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,657.2 Cr | -2.5% | 0.1% | 17.5% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,685.8 Cr | -7.2% | -2.8% | 41% | Stock Analytics | |
VENKYS (INDIA) | ₹2,285.5 Cr | -1.3% | -0.5% | -13.1% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,475.9 Cr | -0.8% | -2.7% | -29.7% | Stock Analytics | |
INDO US BIOTECH | ₹302.3 Cr | -10.2% | -0.5% | -28% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | 1.5% |
9.3% |
-0.2% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses